Muhammad Bilal Ibrahim

ORCID: 0000-0001-9750-6881
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • Cancer Diagnosis and Treatment
  • COVID-19 and healthcare impacts
  • Pancreatitis Pathology and Treatment
  • Colorectal Cancer Screening and Detection
  • Diagnosis and treatment of tuberculosis
  • Economic and Financial Impacts of Cancer
  • Palliative Care and End-of-Life Issues
  • Cancer Risks and Factors
  • Infectious Diseases and Tuberculosis
  • Nutrition and Health in Aging
  • Viral gastroenteritis research and epidemiology
  • Liver Disease Diagnosis and Treatment
  • Gastric Cancer Management and Outcomes
  • Inflammatory Bowel Disease
  • Multiple and Secondary Primary Cancers
  • Cytomegalovirus and herpesvirus research
  • Bariatric Surgery and Outcomes
  • Tuberculosis Research and Epidemiology
  • Global Cancer Incidence and Screening
  • Management of metastatic bone disease
  • Viral-associated cancers and disorders
  • Hepatitis C virus research
  • Liver Diseases and Immunity
  • Dysphagia Assessment and Management

John H. Stroger, Jr. Hospital of Cook County
2023-2024

Aga Khan University Hospital
2023-2024

Aga Khan University
2023

e18839 Background: Cancer, as well immunosuppression from chemotherapy, aggravates thromboembolism risk. The risk is likely amplified in an additive fashion with COVID-19 infection, which confers a higher of VTE viral sepsis, endothelial inflammation, and microthrombi formation. Numerous studies have shown the heightened pulmonary embolism among severe patients. We sought to evaluate further extent COVID-19-associated coagulopathy associated outcomes. Methods: National Inpatient Sample 2020...

10.1200/jco.2023.41.16_suppl.e18839 article EN Journal of Clinical Oncology 2023-06-01

Introduction: Cytomegalovirus colitis (CMV Colitis) is predominantly a disease of the immunocompromised and has been known to affect patients with inflammatory bowel (IBD). Multiple factors, including altered immune system, disrupted mucosal barrier, use immunomodulators, predispose IBD CMV disease. We aim analyze incidence Colitis in hospitalized its impact on hospital outcomes. Methods: National Inpatient Sample Database from 2016-2020 was queried identify hospitalizations using ICD-10...

10.14309/01.ajg.0000950688.15660.b8 article EN The American Journal of Gastroenterology 2023-10-01

624 Background: Cancer is a well-established risk factor for the development of pulmonary embolism (PE), especially the. gastrointestinal (GI) cancers. While multiple studies have reported burden PE in cancer patients, recent data comparing in-hospital outcomes among different types patients are lacking. This study aimed to investigate clinical and healthcare utilization hospitalized with acute context Methods: A cross-sectional was conducted using from National Inpatient Sample (2016-2020)....

10.1200/jco.2024.42.3_suppl.624 article EN Journal of Clinical Oncology 2024-01-20

256 Background: Despite advances in H. pylori screening and eradication, gastric cancer remains a significant public health issue as the 4th most common globally. Racial ethnic disparities disease presentation, surgical intervention, healthcare burden United States are not well understood. Methods: We retrospectively analyzed National Inpatient Sample data (2016-2020) for hospitalizations patients ≥18 years. Primary outcome was in-hospital mortality. Secondary outcomes included gastrectomy,...

10.1200/jco.2024.42.3_suppl.256 article EN Journal of Clinical Oncology 2024-01-20

569 Background: Obesity, a prominent issue in global health, is known to increase the risk factors associated with variety of cancers, including hepatocellular carcinoma (HCC), most common type primary liver cancer. While existing research affirms heightened developing HCC individuals obesity, there remains significant gap understanding specific influences obesity on outcomes patients admitted diagnosis during their index hospital admission. This study explores mortality rate, length stay...

10.1200/jco.2024.42.3_suppl.569 article EN Journal of Clinical Oncology 2024-01-20

255 Background: Metastatic epidural spinal cord compression (MESCC) is an oncologic emergency which can be associated with poor outcomes for cancer patients. Our aim was to study the differences in of MESCC patients gastric (GC-MESCC) compared those other solid malignancies. Methods: Healthcare Cost and Utilization Project-Nationwide Inpatient Sample database (2016-2020) queried identify all (breast, prostate, lung, gastrointestinal, renal thyroid) admitted compression. Multivariate logistic...

10.1200/jco.2024.42.3_suppl.255 article EN Journal of Clinical Oncology 2024-01-20

Epinephric diverticula are distal esophageal pouches protruding from the epithelial lining of esophagus while leiomyomas benign smooth muscle lesions that constitute a significant percentage all gastrointestinal leiomyomas. and common individually but their co-existence is rare. Moreover, they present asymptomatically can occasionally with complains dysphagia weight loss. In this paper, we 58-year-old Asian man three months history indigestion progressive Preoperatively, CT Scan IV Contrast...

10.1016/j.radcr.2024.03.017 article EN cc-by-nc-nd Radiology Case Reports 2024-03-30

298 Background: Although global incidence of gastric cancer has been decreasing over the past decades, an upward trend reported in younger patients and certain ethnic groups few years. The reason for this epidemiological is not fully understood, but differences presentation prognosis suggest that young might represent a different clinical entity. Here, we seek to identify demographic characteristics outcomes between adults older admitted cancer. Methods: Using National Inpatient Sample (NIS)...

10.1200/jco.2023.41.4_suppl.298 article EN Journal of Clinical Oncology 2023-01-24

e21526 Background: Palliative care improves the quality of life in cancer patients; however, there is no literature on specific factors that predict its use patients with malignant melanoma. We explored prevalence trends, and predictors palliative utilization among hospitalized Methods: Retrospective analyses were conducted using National Inpatient Sample (NIS) data collected between 2016 2020. Descriptive multivariable regression models used to investigate sociodemographic hospital-level...

10.1200/jco.2023.41.16_suppl.e21526 article EN Journal of Clinical Oncology 2023-06-01

e18821 Background: Kaposi sarcoma (KS) is a type of soft tissue due to infection with human herpes virus 8 (HHV-8) and can be associated acquired immunodeficiency syndrome [AIDS]. Recent national population data are scarce on reasons for hospitalizations, epidemiology, hospitalization outcomes patients KS in the United States (U.S). Methods: Data were abstracted from National Inpatient Sample (NIS) Database. This database largest collection inpatient admission U.S. It 20-percent stratified...

10.1200/jco.2023.41.16_suppl.e18821 article EN Journal of Clinical Oncology 2023-06-01

e18823 Background: Cancer patients are at a higher risk of venous thromboembolism and fatal pulmonary embolism due to inflammatory cytokines, reduced coagulation inhibitors, microparticles, other molecular mechanisms. COVID-19 leads endothelial inflammation microthrombi formation, further aggravating the baseline profound among cancer patients, with subsequent worsened mortality morbidity. We sought explore outcomes COVID-19-associated VTE in patients. Methods: National Inpatient Sample 2020...

10.1200/jco.2023.41.16_suppl.e18823 article EN Journal of Clinical Oncology 2023-06-01

8589 Background: Superior Vena Cava Syndrome (SVCS) is a condition characterized by obstruction of the SVC that can commonly be caused thrombus formation in SVC. Small cell lung cancer (SCLC) frequently results When severe enough, SVCS present as life-threatening oncological emergency. In this study we aim to explore baseline characteristics thrombosis (SVCT) patients with SCLC, prevalence US hospitalizations, and disparities regards race socioeconomic status. Methods: National Inpatient...

10.1200/jco.2023.41.16_suppl.8589 article EN Journal of Clinical Oncology 2023-06-01

e16318 Background: Pancreatic cancer patients have a strong risk of Deep Venous thrombosis (DVT). Pulmonary Embolism (PE) can be fatal complication DVT. Both DVT/PE increases the hospitalization and subsequent readmission. National population-based studies are scarce on readmissions among pancreatic in United States (U.S). In this study, we aim to describe rate, reasons for readmissions, outcome hospitalized U.S. Methods: We analyzed 2018 Nationwide Readmissions Database (NRD). It includes...

10.1200/jco.2023.41.16_suppl.e16318 article EN Journal of Clinical Oncology 2023-06-01

e15663 Background: Colorectal cancer (CRC) is the third most commonly occurring in both men and women United States second common cause of mortality. Tremendous efforts have been made last few decades to increase awareness about colon importance screening early detection. In this study we aimed trend cases over years (2000-2019) Using SEER database. Methods: Patients diagnosed with between 2000 2019 were extracted from Surveillance, Epidemiology, Final Results (SEER) Year diagnosis, age,...

10.1200/jco.2023.41.16_suppl.e15663 article EN Journal of Clinical Oncology 2023-06-01

e24114 Background: Gastrointestinal (GI) cancers account for a large proportion of cancer-related deaths and are often associated with significant impairment in quality life, even at earlier stages. Although guidelines recommend early palliative care (PC) involvement all patients advanced cancer, select stages, implementation these practices has been highly variable. Methods: Using the National Inpatient Sample (NIS) database, we selected adult admitted primary diagnosis any GI malignancy...

10.1200/jco.2023.41.16_suppl.e24114 article EN Journal of Clinical Oncology 2023-06-01

e16327 Background: COVID-19 infections have been known to cause worse outcomes in patients with underlying co-morbid conditions. Currently, there is limited data regarding re-admissions such after infection. So, we pursued assess the rates, predictors, and causes of re-admission infection who had gastrointestinal malignancy. Methods: The National Readmission Database for 2020 was analyzed identify hospitalizations also a co-diagnosis GI Data gathered, at 30 90 days initial hospitalization....

10.1200/jco.2023.41.16_suppl.e16327 article EN Journal of Clinical Oncology 2023-06-01

e17033 Background: Penile cancer (PC) is a rare malignancy that more common in developing countries. However, recent studies have shown rising incidence-based mortality the United States (U.S). National population data scarce on reasons for hospitalizations, epidemiology, and hospitalization outcomes of patients with PC. Methods: Data were abstracted from Inpatient Sample (NIS) 2020 Database. T≥his database largest collection inpatient admission U.S. It 20-percent stratified sample all...

10.1200/jco.2023.41.16_suppl.e17033 article EN Journal of Clinical Oncology 2023-06-01

e16177 Background: Cholangiocarcinomas (CCAs) are epithelial malignancies arising from the biliary ductal system, occurring with an incidence of 1/100,000 people per year in US. Most patients present advanced-stage disease and prognosis is very poor, five-year mortality rates ranging 2-24% depending on stage subtype. This study was designed to determine trends adverse outcomes CCA. Methods: retrospective trend analyzes data Nationwide Inpatient Sample (NIS) for years 2016-2020 identify adult...

10.1200/jco.2023.41.16_suppl.e16177 article EN Journal of Clinical Oncology 2023-06-01

e14004 Background: Leptomeningeal metastasis (LM) is a rare but devastating manifestation of cancer metastasis. Most solid tumors are known to cause LM, the most common etiology breast and lung cancer. The incidence LM has been increasing due increased survival rates secondary improved systemic treatment. Here we aim explore baseline characteristics, epidemiologic differences, palliative care utilization. hospital outcomes LM. Methods: Nationwide Inpatient Sample (NIS) database 2016-2019 was...

10.1200/jco.2023.41.16_suppl.e14004 article EN Journal of Clinical Oncology 2023-06-01
Coming Soon ...